| http://dbpedia.org/ontology/abstract
|
Omarigliptin (MK-3102) is a potent, long-a … Omarigliptin (MK-3102) is a potent, long-acting oral antidiabetic drug of the DPP-4 inhibitor class used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co. It inhibits DPP-4 to increase incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying and decreases blood glucose levels.ptying and decreases blood glucose levels.
, 奥格列汀，即Omarigliptin (MK-3102) ，是一种强效且长效的口服用抗糖尿病药，是一类DPP-4抑制剂。该药物致力于使得2型糖尿病患者能够将用药频率降低到一周一次。该药物由默克藥廠开发。该药物通过抑制DPP-4来提升水平(GLP-1和)，从而抑制胰高血糖素释放，使得胰岛素分泌增加，减缓胃排空，降低血糖水平。
|
| http://dbpedia.org/ontology/casNumber
|
1226781-44-7
|
| http://dbpedia.org/ontology/chEMBL
|
2105762
|
| http://dbpedia.org/ontology/fdaUniiCode
|
CVP59Q4JE1
|
| http://dbpedia.org/ontology/kegg
|
D10317
|
| http://dbpedia.org/ontology/pubchem
|
46209133
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Omarigliptin.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
47880585
|
| http://dbpedia.org/ontology/wikiPageLength
|
6123
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1084239756
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Insulin +
, http://dbpedia.org/resource/Linagliptin +
, http://dbpedia.org/resource/Blood_glucose +
, http://dbpedia.org/resource/Category:Dipeptidyl_peptidase-4_inhibitors +
, http://dbpedia.org/resource/Sitagliptin +
, http://dbpedia.org/resource/Gastric_inhibitory_polypeptide +
, http://dbpedia.org/resource/Saxagliptin +
, http://dbpedia.org/resource/Antidiabetic_drug +
, http://dbpedia.org/resource/Vildagliptin +
, http://dbpedia.org/resource/Glucagon +
, http://dbpedia.org/resource/Incretin +
, http://dbpedia.org/resource/Category:Phenylethanolamine_ethers +
, http://dbpedia.org/resource/DPP-4_inhibitor +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/Merck_&_Co. +
, http://dbpedia.org/resource/Dipeptidyl_peptidase-4_inhibitor +
, http://dbpedia.org/resource/GLP-1 +
, http://dbpedia.org/resource/Type_2_diabetes +
, http://dbpedia.org/resource/Alogliptin +
, http://dbpedia.org/resource/Category:Sulfonamides +
, http://dbpedia.org/resource/Category:Merck_&_Co._brands +
, http://dbpedia.org/resource/Pharmaceuticals_and_Medical_Devices_Agency +
|
| http://dbpedia.org/property/atcPrefix
|
None
|
| http://dbpedia.org/property/c
|
17
|
| http://dbpedia.org/property/casNumber
|
1226781
|
| http://dbpedia.org/property/chembl
|
2105762
|
| http://dbpedia.org/property/chemspiderid
|
28424182
|
| http://dbpedia.org/property/f
|
2
|
| http://dbpedia.org/property/h
|
20
|
| http://dbpedia.org/property/iupacName
|
-2
|
| http://dbpedia.org/property/kegg
|
D10317
|
| http://dbpedia.org/property/legalStatus
|
Developing
|
| http://dbpedia.org/property/n
|
4
|
| http://dbpedia.org/property/o
|
3
|
| http://dbpedia.org/property/pubchem
|
46209133
|
| http://dbpedia.org/property/routesOfAdministration
|
Oral
|
| http://dbpedia.org/property/s
|
1
|
| http://dbpedia.org/property/smiles
|
CSn1cc2cCN[C@@H]3C[C@@H]N
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
MKMPWKUAHLTIBJ-ISTRZQFTSA-N
|
| http://dbpedia.org/property/synonyms
|
MK-3102
|
| http://dbpedia.org/property/unii
|
CVP59Q4JE1
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Oral_hypoglycemics +
, http://dbpedia.org/resource/Template:Merck&Co +
, http://dbpedia.org/resource/Template:Infobox_drug +
, http://dbpedia.org/resource/Template:Gastrointestinal-drug-stub +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Sulfonamides +
, http://dbpedia.org/resource/Category:Phenylethanolamine_ethers +
, http://dbpedia.org/resource/Category:Merck_&_Co._brands +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/Category:Dipeptidyl_peptidase-4_inhibitors +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Omarigliptin?oldid=1084239756&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Omarigliptin.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Omarigliptin +
|
| owl:sameAs |
https://global.dbpedia.org/id/zLCW +
, http://www.wikidata.org/entity/Q21098979 +
, http://vi.dbpedia.org/resource/Omarigliptin +
, http://zh.dbpedia.org/resource/%E5%A5%A5%E6%A0%BC%E5%88%97%E6%B1%80 +
, http://yago-knowledge.org/resource/Omarigliptin +
, http://dbpedia.org/resource/Omarigliptin +
|
| rdf:type |
http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
奥格列汀，即Omarigliptin (MK-3102) ，是一种强效且长效的口服用抗糖尿病药，是一类DPP-4抑制剂。该药物致力于使得2型糖尿病患者能够将用药频率降低到一周一次。该药物由默克藥廠开发。该药物通过抑制DPP-4来提升水平(GLP-1和)，从而抑制胰高血糖素释放，使得胰岛素分泌增加，减缓胃排空，降低血糖水平。
, Omarigliptin (MK-3102) is a potent, long-a … Omarigliptin (MK-3102) is a potent, long-acting oral antidiabetic drug of the DPP-4 inhibitor class used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co. It inhibits DPP-4 to increase incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying and decreases blood glucose levels.ptying and decreases blood glucose levels.
|
| rdfs:label |
奥格列汀
, Omarigliptin
|
